Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer.

@article{Hsu2005CombinedMT,
  title={Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer.},
  author={I Chow Joe Hsu and Alvin R Cabrera and Vivian K. Weinberg and Joycelyn L Speight and Alexander R. Gottschalk and Mack Roach and Katsuto Shinohara},
  journal={Brachytherapy},
  year={2005},
  volume={4 3},
  pages={202-6}
}
PURPOSE This is a retrospective review of our experience using high-dose-rate (HDR) brachytherapy boost for prostate cancer. METHODS AND MATERIALS During the study period, we recommended external beam radiotherapy (45 Gy) and HDR boost (18 Gy in three fractions) combined with hormonal therapy (HT) for 2 months before and during radiotherapy to patients with at least one of the following risk features: pretreatment prostate-specific antigen>10, Gleason score (GS)>or=7, and clinical T3 disease… CONTINUE READING